Financial Services
Cypherpunk Technologies Inc.(CYPH)
Live Price
Offline$0.739
-3.02% today
1Y Change
+162.06%
Window
Jun 25, 2025 β Jun 18, 2026
- Market Cap
- $60.00M
- Revenue Growth
- 0.0%
- EPS Growth
- +104.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars Β· Jun 25, 2025 β Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cypherpunk Technologies Inc. (CYPH) is a Financial Services stock with a market cap of $60.00M and listed on NASDAQ. The stock last traded around $0.74 and up 162.1% across the available one-year price window (Jun 25, 2025 β Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +104.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +104.0%, free cash flow +27.2% with operating margin -19649.3% and ROIC -12.4%. Valuation already assumes a fairly strong business story at price/sales 290.0. Stock Foundry combines CYPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +3.4% peer median
Operating Margin
Below sector median
-19649.3% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +104.0%, while operating margin sits near -19649.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +22.2% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | β | +15.4% | +22.1% | -34.8% |
2026 Mar 16, 2026 | -246.4% | +12.6% | +1.1% | +34.8% |
2025 Nov 12, 2025 | +66.7% | -14.1% | +43.4% | -22.9% |
Benchmark Edge
CYPH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CYPH
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CYPH Max Drawdown
-82.69%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CYPH and SPY.
Company Overview
Cypherpunk Technologies Inc.
NASDAQ
Cypherpunk Technologies Inc. is a biopharmaceutical company focused on developing novel antibody therapies for cancer treatment, with a strategic emphasis on biomarker-targeted approaches. The companyβs lead clinical-stage candidate, DKN-01, is a monoclonal antibody designed to inhibit Dickkopf-related protein 1 and is currently being evaluated in multiple clinical trials for esophagogastric, gynecologic, and colorectal cancers. Additional pipeline assets include FL-301, targeting Claudin18.2-expressing cells, and preclinical programs FL-302 and FL-501. Cypherpunk Technologies also distinguishes itself with a unique digital asset treasury strategy, actively acquiring and holding Zcash (ZEC) as part of its long-term value-building initiative. The companyβs research and development operations are conducted through its wholly-owned subsidiary, Leap Therapeutics, Inc. Headquartered in Cambridge, Massachusetts, Cypherpunk Technologies operates at the intersection of biotechnology innovation and digital asset investment, reflecting its dual commitment to advancing cancer therapies and supporting privacy-focused technologies.
- Leadership
- Mr. Douglas E. Onsi J.D.
- Employees
- 6
- Street Address
- 47 Thorndike Street, Suite B1-1
- Mailing
- Cambridge, MA, 02141
- Region
- Cambridge, MA, United States
- Last Updated
- May 10, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- β
- Price/Sales
- 290.0
- Price/Book
- 0.5
Growth
- Revenue
- 0.0%
- EPS
- +104.0%
- Free Cash Flow
- +27.2%
Profitability
- Gross Margin
- -9631.6%
- Operating Margin
- -19649.3%
- Net Margin
- -8537.8%
- ROE
- -16.9%
- ROIC
- -12.4%
Balance Sheet
- Debt/Equity
- 0.00
- Current Ratio
- 35.56
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.